NCCR*Explorer

Get Started with a Cancer Site Help?

The NCCR*Explorer application uses the International Classification of Childhood Cancer (ICCC) coding schema to classify cancer cases. The ICCC Recode Third Edition ICD-O-3/IARC 2017 has the definitions for each cancer site.
To compare multiple cancer sites on the same graph, select the Compare Cancer Sites option.
Select from the list or begin typing a cancer site name to find the available sites that match your term.

Choose a Statistic to Explore Help?

Incidence
Incidence is the number of new cases of the specific cancer site/type per 100,000 people in the U.S.
U.S. Mortality
Cancer Mortality is the number of deaths caused by a specific cancer site/type per 100,000 people in the U.S.
Survival
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer.
Prevalence
Cancer Prevalence is the number or percent of people alive on a certain date who have been diagnosed with cancer.
Risk of Diagnosis/Dying
Lifetime risk is the probability of developing or dying from cancer in the course of one's lifespan.

Refer to the Help Guide for more information.

Graph Type Help?

Trends Over Time
Recent trends present the observed (points) and modeled (lines) annual age-adjusted rates and corresponding annual percent change (APC) trend for each joinpoint segment in the table.
Recent Rates
Recent rates present the age-adjusted rate for the aggregated five most recent years of the available data, in a bar chart format.
Rates by Age
Rates by age refer to a rate for a single age for the most recent 5-year time period.

Recent Trends
Recent trends present observed (points) and predicted (lines) relative survival by time since diagnosis (1 year, 3 years, 5 years) and corresponding trend shown in table.
5-Year Survival
5-year relative survival rates show the estimated percentage of patients who would be expected to survive the effects of their cancer 5 years or more after cancer diagnosis.
By Time Since Diagnosis
Survival by time since diagnosis provides a view of the percentage of people surviving by year after diagnosis in up to 10 years.
Conditional Survival
Conditional survival show the 5-year relative survival rates for patients conditioned on the patient having already survived 0, 1, 3, or 5 years since the cancer diagnosis.

Complete
Complete prevalence represents the proportion of people alive on a certain day who previously had a diagnosis of the disease, regardless of how long ago the diagnosis was, or whether the patient is still under treatment or is considered cured.
Limited Duration
Limited-duration prevalence represents the proportion of people alive on a certain day who had a diagnosis of the disease within the past 25 years.

Refer to the Help Guide for more information.

To ensure your graph is easy to interpret, we recommend 12 or fewer selections. If more than 12 selections are made, only the data table will be shown.

All cancers are malignant unless otherwise noted.

All ICCC Groups Combined

I. Leukemias

Show SubtypesHide Subtypes

a. Lymphoid Leukemias

b. Acute Myeloid Leukemias

c. Chronic Myeloproliferative Diseases

d. Myelodysplastic Syndrome And Other Myeloproliferative Diseases

e. Unspecified And Other Specified Leukemias

II. Lymphomas

Show SubtypesHide Subtypes

a. Hodgkin Lymphomas

b. Non-Hodgkin Lymphomas (excl. Burkitt)

c. Burkitt Lymphoma

(b + c) Non-Hodgkin and Burkitt Lymphomas

d. Miscellaneous Lymphoreticular Neoplasms

e. Unspecified Lymphomas

III. Central Nervous System Neoplasms (Malignant)

Show SubtypesHide Subtypes

a. Ependymomas And Choroid Plexus Tumor (Malignant)

b. Astrocytomas (Malignant)

c. Intracranial/Intraspinal Embryonal Tumors (Malignant)

d. Other Gliomas (Malignant)

e. Other Specified Intracranial/Intraspinal Neoplasms (Malignant)

f. Unspecified Intracranial/Intraspinal Neoplasms (Malignant)

III. Central Nervous System Neoplasms (Non-Malignant)

Show SubtypesHide Subtypes

a. Ependymomas And Choroid Plexus Tumor (Non-Malignant)

b. Astrocytomas (Non-Malignant)

c. Intracranial/Intraspinal Embryonal Tumors (Non-Malignant)

d. Other Gliomas (Non-Malignant)

e. Other Specified Intracranial/Intraspinal Neoplasms (Non-Malignant)

f. Unspecified Intracranial/Intraspinal Neoplasms (Non-Malignant)

IV. Neuroblastoma

Show SubtypesHide Subtypes

a. Neuroblastoma/Ganglioneuroblastoma

b. Other Peripheral Nervous Cell Tumors

V. Retinoblastoma

VI. Renal Tumors

Show SubtypesHide Subtypes

a. Nephroblastoma

b. Renal Carcinomas

c. Unspecified Renal Tumors

VII. Hepatic Tumors

Show SubtypesHide Subtypes

a. Hepatoblastoma/Mesenchymal Tumors Of Liver

b. Hepatic Carcinomas

c. Unspecified Hepatic Tumors

VIII. Bone Tumors

Show SubtypesHide Subtypes

a. Osteosarcomas

b. Chondrosarcomas

c. Ewing Tumor And Related Sarcomas Of Bone

d. Other Specified Bone Tumors

e. Unspecified Bone Tumors

IX. Soft Tissue Tumors

Show SubtypesHide Subtypes

a. Rhabdomyosarcomas

b. Fibrosarcomas/Peripheral Nerve Sheath Tumors

c. Kaposi Sarcoma

d. Other Specified Soft Tissue Sarcomas

e. Unspecified Soft Tissue Sarcomas

X. Germ Cell Tumors (Malignant)

Show SubtypesHide Subtypes

a. Intracranial/Intraspinal Germ Cell Tumors (Malignant)

b. Extracranial/Extragonadal Germ Cell Tumors (Malignant)

c. Gonadal Germ Cell Tumors (Malignant)

d. Gonadal Carcinomas (Malignant)

e. Other And Unspecified Gonadal Tumors (Malignant)

X. Germ Cell Tumors (Non-Malignant)

Show SubtypesHide Subtypes

a. Intracranial/Intraspinal Germ Cell Tumors (Non-Malignant)

XI. Epithelial Neoplasms And Melanomas

Show SubtypesHide Subtypes

a. Adrenocortical Carcinomas

b. Thyroid Carcinomas

c. Nasopharyngeal Carcinomas

d. Melanomas

e. Skin Carcinomas

f. Other And Unspecified Carcinomas

XII. Other/Unspecified Neoplasms

Show SubtypesHide Subtypes

a. Other Specified Tumors

b. Other Unspecified Tumors

Cancel

Additional Comparison

Age Range:

More Options

Precision:

Show Standard Error

Show Confidence Interval

Group Distribution by Stage

Display Prevalence As: Counts

Percent of U.S. population

Display Prevalence As: Counts

Percent of U.S. population

Age-adjusted percent of U.S. population

By NCCR Registries, representing up to 69% of all U.S. children, adolescents, and young adults (see footnote for included registries)

URL Copied to Clipboard

Graph
Data Table

Tap on points for more details.

View APC

Annual Percent Change (APC)

Choose an option:

Year Range	APC %	Direction

No trend estimates available

Table Display: Trends

Rates

Regression Line Segment Trends (shown on graph)

Recent 5 and 10 Year Trends

Data Source
Methodology
Race/Ethnicity Coding
Cancer Site Coding

Data Source

Source Footnote

Methodology

Additional Footnote

Race/Ethnicity Coding

Additional Footnote

Cancer Site Coding

Additional Footnote

Download and Share

This functionality is not fully supported in Internet Explorer. Please use a different browser or take a screenshot.

Image Preview

Title

Legend

Footnotes

Image Options Show Titles

Show Legend

Show Footnotes

Graph Size